4093 CofE-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 1 | 0.2 | 6.55× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 0.3 | 3.67× | not tested | |
| Homogeneous metal compounds | 1 | 0.5 | 2.07× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04315 | GDP | Guanosine-5'-Diphosphate | 3 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 6 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 4 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 3 |
| NAmetal | SODIUM ION | 2 |
| F42 | COENZYME F420 | 1 |
| F4I | (2~{S})-2-[[(2~{S})-2-[oxidanyl-[(2~{R},3~{S},4~{S})-2,3,4-tris(oxidanyl)-5-[2,4,8-tris(oxidanylidene)-1,9-dihydropyrimido[4,5-b]quinolin-10-yl]pentoxy]phosphoryl]oxypropanoyl]amino]pentanedioic acid | 1 |